Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
Creators
- 1. Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich (Germany)
- 2. Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich (Germany)
- 3. Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich (Germany)
- 4. German Cancer Consortium (DKTK), partner site Munich, and German Cancer Research Center (DKFZ), Heidelberg (Germany)
Description
The aim of the present study was to evaluate the influence of the applied safety margins of modern intensity-modulated radiotherapy (IMRT) in patients with high-grade meningiomas on local control and recurrence patterns. Twenty patients with a neuropathological diagnosis of a high-grade meningioma (WHO°II or °III) treated with adjuvant or definitive radiotherapy between 2010 and 2015 were included in the present retrospective analysis. All patients were planned PET-based. Recurrence patterns were assessed by means of MRI and/or DOTATATE-PET/computertomography (CT). The median follow-up was 31.0 months [95% confidence interval (CI): 20.1–42.0] and the progression-free survival (PFS) after 24 months was 87.5%. Overall, four patients had a local recurrence of their meningioma. Of these, three were located in field according to the prior radiotherapy treatment region, while only one patient had a distant relapse. There were no independent factors influencing progression-free or overall survival (OS). After radiotherapy (RT), patients with atypical or anaplastic meningiomas still have a defined risk of tumor recurrence. The aim of the present study was to examine mono-institutional data concerning target volume definition and recurrence patterns after radiotherapy of high-grade meningiomas as there are limited data available. Our data suggest that extended safety margins are necessary to achieve a favorable local control for high-grade meningiomas.
Availability note (English)
Available from http://dx.doi.org/10.1186/s13014-018-1056-4; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000954Additional details
Identifiers
Publishing Information
- Journal Title
- Radiation Oncology (Online)
- Journal Volume
- 13
- Journal Page Range
- vp.
- ISSN
- 1748-717X
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49082609
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- NMR IMAGING; PATIENTS; RADIATION HAZARDS; RADIOTHERAPY
- Descriptors DEC
- DIAGNOSTIC TECHNIQUES; HAZARDS; HEALTH HAZARDS; MEDICINE; NUCLEAR MEDICINE; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) The Author(s). 2018
- Notes
- PMCID: PMC6000954; PMID: 29898747; PUBLISHER-ID: 1056; OAI: oai:pubmedcentral.nih.gov:6000954